Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Superiority of CRx-102 Over Each of Its Components When Given to Subjects With Active Rheumatoid Arthritis (RA)

NCT00551707 is registered in ClinicalTrials.gov with Zalicus as lead sponsor.

NCT NCT00551707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Superiority of CRx-102 Over Each of Its Components When Given to Subjects With Active Rheumatoid Arthritis (RA)
Lead sponsor
Zalicus
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
January 31, 2009
Enrollment
51 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis